Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "S-1"

861 News Found

Jupiter Life Line Hospitals lists at 32.38% premium
News | September 20, 2023

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +


USFDA delegation visits Amneal Pharmaceutical facility in Matoda
News | September 02, 2023

USFDA delegation visits Amneal Pharmaceutical facility in Matoda

Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities


Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection
Drug Approval | September 02, 2023

Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection

The inspection has concluded successfully on 1st September 2023 without any critical/major observation


Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
News | August 23, 2023

Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round

Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO


Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
News | August 22, 2023

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment


Cipla launches knowledge sharing platform ‘Ciplamed 2.0’
Digitisation | August 16, 2023

Cipla launches knowledge sharing platform ‘Ciplamed 2.0’

CiplaMed 2.0 leverages advanced analytics and automation


Eugia Pharma receives USFDA Approval for Icatibant Injection
Drug Approval | August 16, 2023

Eugia Pharma receives USFDA Approval for Icatibant Injection

This is the 166th ANDA out of Eugia Pharma Speciality Group facilities


LyondellBasell awarded the 2023 Global Medical Plastics Company of the year
News | August 13, 2023

LyondellBasell awarded the 2023 Global Medical Plastics Company of the year

LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions


Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr
News | August 06, 2023

Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr

The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023


USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Drug Approval | August 05, 2023

USFDA approves Merck’s ERVEBO for use in children 12 months of age and older

Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease